Log In
BCIQ
Print this Print this
 

PF-04136309

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionCC chemokine receptor 2 (CCR2) antagonist
Molecular Target CC chemokine receptor 2 (CCR2) (CD192)
Mechanism of ActionCC chemokine receptor 2 (CCR2) antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today